(Q54702700)

3 June 2018

title

In-vitro activity of cephalothin/kanamycin and methicillin/kanamycin combinations against methicillin-resistant Staphylococcus aureus. (English)

1 reference

3 June 2018

methicillin-resistant Staphylococcus aureus

main subject

0 references

Staphylococcus aureus

1 reference

R J Bulger

1

1 reference

3 June 2018

language of work or name

English

0 references

publication date

1 January 1967

1 reference

3 June 2018

published in

The Lancet

1 reference

3 June 2018

volume

1

1 reference

3 June 2018

page(s)

17-19

1 reference

3 June 2018

issue

7480

1 reference

3 June 2018

Present status of therapy with combinations of antibiotics

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2867%2992422-1

7 January 2021

Penicillinase production and intrinsic resistance to penicillins in Staphylococcus aures.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2867%2992422-1

7 January 2021

INACTIVATION OF METHICILLIN, OXACILLIN, CLOXACILLIN, AND CEPHALOTHIN BY STAPHYLOCOCCAL PENICILLINASE

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2867%2992422-1

7 January 2021

The rationale and management of combined therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2867%2992422-1

7 January 2021

Methods and significance of in vitro testing of bacterial sensitivity to drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2867%2992422-1

7 January 2021

Evolutio of natural resistance to the newer penicillins.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2867%2992422-1

7 January 2021

10.1016/S0140-6736(67)92422-1

Identifiers

DOI

1 reference

3 June 2018

PubMed ID

4163737

1 reference

3 June 2018